Insider Purchases: Inside the Buy

Tag: KMB

Illustration of Kimberly-Clark brands (tissues and diapers) alongside a Band-Aid and pill bottle, symbolizing KMB’s shift toward health and personal care while highlighting its high dividend yield.

February 10, 2026

Band-Aids & Bottom Lines: Why Kimberly-Clark’s 5% Yield Is the Ultimate Turnaround Play

KMB isn’t flashy—but it might be one of 2026’s sneakiest high-yield turnarounds. A $1M insider buy, heavy institutional ownership, and a big strategic pivot (hello, Tylenol & Band-Aids via Kenvue) have the market nervous… and contrarians intrigued.

Read entire article

Tags: buy or sell kmb, Consumer Staples, contrarian investment, contrarian play, Defensive Stocks, director buying, Dividend aristocrat, Dividend Stocks, featured-insiders, funanc1al edge, funanc1al investing, Healthcare & Personal Care, hub-insiders, Income Investing, Insider Buying, kenvue, Kimberly-Clark, KMB, merger, Risks buying KMB, share buyback, Todd Maclin, turnaround play, Turnaround Stories, Value Investing, why buy KMB

Your cart

Insider Purchases: Inside the Buy

Tag: KMB

February 10, 2026

Band-Aids & Bottom Lines: Why Kimberly-Clark’s 5% Yield Is the Ultimate Turnaround Play

Quick links

Contact us

About us

Follow us